Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real World Evidence Clinical Utility Study of KidneyIntelX in Patients With Type 2 Diabetes and Chronic Kidney Disease

NCT04802395 is registered in ClinicalTrials.gov with Renalytix AI, Inc. as lead sponsor.

NCT NCT04802395
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04802395 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real World Evidence Clinical Utility Study of KidneyIntelX in Patients With Type 2 Diabetes and Chronic Kidney Disease
Lead sponsor
Renalytix AI, Inc.
Phase
Observational
Overall status
Recruiting
Start date
March 2, 2021
Completion date
December 1, 2026
Enrollment
10,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney diseases, diabetic kidney disease